Did vnda get fda approval today

Vanda Pharmaceuticals (VNDA) has not received FDA approval today. Here is the FDA approval status for VNDA's drugs: 1. **Fanapt (iloperidone)**: This drug was approved on April 2, 2024, for indications such as bipolar depression, bipolar disease, and mental health. 2. **HETLIOZ (tasimelteon)**: This drug is pending FDA approval as of March 4, 2024, for the indication of insomnia. 3. **Tradipitant**: This drug is also pending FDA approval as of September 18, 2024, for the indication of gastroparesis.